Actively Recruiting

Phase Not Applicable
Age: 65Years - 85Years
All Genders
NCT04629391

Anatomic TSA Vs RTSA for Glenohumeral Arthritis

Led by La Tour Hospital · Updated on 2024-10-26

296

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.

CONDITIONS

Official Title

Anatomic TSA Vs RTSA for Glenohumeral Arthritis

Who Can Participate

Age: 65Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Primary glenohumeral arthritis
  • Intact rotator cuff
  • No significant glenoid bone loss
  • Patients aged between 65 and 85 years
  • Provided informed consent documented by signature
Not Eligible

You will not qualify if you...

  • B2 glenoid with >80% posterior humeral head subluxation or >25 degrees neoglenoid retroversion
  • B3 and C type glenoids
  • Full thickness rotator cuff tear
  • Acute or malunited proximal humeral fracture
  • Chronic locked dislocation
  • Rheumatoid arthritis
  • Revision surgery or previous shoulder surgery
  • Tumors
  • Axillary nerve damage
  • Non-functioning deltoid muscle
  • Glenoid vault deficiency preventing baseplate fixation
  • Infection or neuropathic joints
  • Known or suspected non-compliance, drug or alcohol abuse
  • Incapable of judgment or under legal guardianship
  • Inability to follow study procedures due to language, psychological disorders, dementia, or contraindication for CT scan
  • Investigator or related persons' enrolment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

La Tour Hospital

Meyrin, Switzerland, 1217

Actively Recruiting

Loading map...

Research Team

A

Alexandre Lädermann, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here